Caplin Group announces strategic investment of Rs. 700 crore in TN
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
Equipped with most advanced Distributed Control System (DCS) automation technology, the facility has been set up with an investment of Rs. 200 crore
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Lupin enters into BTA with Lupin Manufacturing Solutions
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
Subscribe To Our Newsletter & Stay Updated